UPPER EGYPT PHARMACEUTICALS
The company was acquired by ACDIMA Group during 2017. ACDIMA modified the administrative, financial and technical structure of the company to regain its position as one of the most influential companies in the Egyptian pharmaceutical sector.
The company owns more than 250 products including Cephalosporin, Antibiotics, Cardiovascular drugs, analgesics 7 anti-inflammatory drugs as well as Anesthetics registered with the Egyptian ministry of health.
Secondary Trade Building Entrance No.5, Fifth Area, Sheraton Heliopolis Cairo
+ 02 22673175